❯ it's been a while since I worked on this. Can you please review the code and the gh issues (closed and open) and summarise where we're at. What is the latest output data I can report on in my interim report and what more   
  can we do that's low risk and achievable in a couple of weeks?                                                                                                                                                                 
  
⏺ I'll dig into the current state across several angles in parallel — git history, GitHub issues, the latest lab books, and what output data/figures exist.

⏺ Bash(echo "=== OPEN ISSUES ===" && gh issue list --state open --limit 50 2>&1 | head -60; echo; echo "=== RECENTLY CLOSED ISSUES (last 40) ===" && gh issue list --st…)
  ⎿  === OPEN ISSUES ===
     52 OPEN    MRes thesis: finish Zotero-sourced bibliography for reports/thesis/     documentation, tech     2026-06-02T09:03:09Z
     50 OPEN    Migrate to Vivarium for PhD-scope WCM work (post-dissertation strategic plan)   tech    2026-05-23T20:30:47Z
     … +50 lines (ctrl+o to expand)

  Listed 1 directory (ctrl+o to expand)

⏺ Bash(echo "=== recent commits (30) ===" && git log --oneline -30; echo; echo "=== params dir ===" && ls -la reports/params/ 2>&1; echo; echo "=== thesis dir ===" &&…)
  ⎿  === recent commits (30) ===
     d4984a02 Thesis supplement: support claims, add Vivarium + forward-look, field's verdict on COPASI/VCell
     b47e1bb7 Thesis: add MRes draft, template, COPASI/VCell supplement with PDF+DOCX output
     … +50 lines (ctrl+o to expand)

⏺ Model is at v0.5 now and there's substantial work since the last lab book (kinetics-as-data refactor, thesis draft, dose sweep). Let me read the key recent documents and check what output data/figures exist.

  Read 2 files, listed 1 directory (ctrl+o to expand)

⏺ Let me read the two newest design docs and confirm the current test state.

  Read 2 files (ctrl+o to expand)

⏺ Bash(OPENBLAS_NUM_THREADS=1 PYTHONPATH=$PWD python3 -m pytest models/platelet/tests/ -q 2>&1 | tail -15)
  ⎿  /Library/Frameworks/Python.framework/Versions/3.13/bin/python3: No module named pytest

⏺ The test run grabbed system Python 3.13. Let me use the pinned pyenv interpreter.
 
⏺ Bash(cat .python-version 2>&1; echo "---"; OPENBLAS_NUM_THREADS=1 PYTHONPATH=$PWD pyenv exec python -m pytest models/platelet/tests/ -q 2>&1 | tail -8)
  ⎿  3.11.5
     ---
         self._expression.resetCache()
     … +7 lines (ctrl+o to expand)

⏺ 52/52 tests pass. Let me confirm the current model version string and check the thesis supplementary materials.

  Listed 1 directory (ctrl+o to expand)

⏺ I've now got a full picture — code, tests, issues, the latest data, and the thesis draft. Here's where things stand.

  TL;DR — where you are 

  The model is healthy and stable. 52/52 tests pass, mypy is clean, and the biology hasn't changed since v0.4.1 (2026-05-12) — that was the last functional change. Everything since then has been infrastructure and writeup,
  not new mechanisms:

  - The model is now labelled v0.5, but that bump is the kinetics-as-data refactor (#32), not new biology. All ~150 rate constants moved to reports/params/calcium-v0.5.toml and the 63-species inventory to species-v0.5.tsv,
  both loaded at import. Plus the 2-D dose sweep (#45) and its webapp tab (#46).
  - The MRes draft thesis exists (reports/thesis/draft-thesis.qmd + COPASI/VCell supplement) and is structured against the handbook's Appendix 3.

  So the science is frozen at "12 mechanisms, agonist → Ca²⁺ end-to-end, no hand-fitted forcing, Dolan 2014 Fig. 4 validated 5/5." What's happened in the last month is you made it reportable and extensible, not bigger.

  One gap in "where we are"

  Your lab-book trail goes cold at 2026-05-22. The kinetics-as-data work (10 commits), the TOML reference-verification pass, and the entire thesis draft (June 1–9) have no lab-book entry. Given you said "it's been a while,"
  that's the one piece of recent state that isn't written down anywhere. Worth a 20-minute catch-up lab book so future-you (and Mike) can see what landed.

  Issues snapshot

  Closed — the whole calcium phase (v0.2→v0.4.1: IP3R, SERCA, PMCA+CaM, SOCE, MCU/NCX, PI cycle, buffers), receptor signalling (#9), all three PLAN issues (#14/15/16), and the dose-sweep trio (#44/45/46).

  Open (29) — bucketed:

  ┌────────────────────────────────┬───────────────────────────────────────────────────────────────────────────────────────────────────┬────────────────────────────────────────────┐
  │             Bucket             │                                              Issues                                               │        Notes for the report period         │
  ├────────────────────────────────┼───────────────────────────────────────────────────────────────────────────────────────────────────┼────────────────────────────────────────────┤
  │ Thesis-immediate               │ #52 (finish Zotero bibliography)                                                                  │ Blocks a clean reference list              │
  ├────────────────────────────────┼───────────────────────────────────────────────────────────────────────────────────────────────────┼────────────────────────────────────────────┤
  │ New biology — next phase       │ Granules #5/6/7/8; receptors #10 P2Y12, #33 TP, #34 GPVI                                          │ Each ~1–2 weeks; needs new validation data │
  ├────────────────────────────────┼───────────────────────────────────────────────────────────────────────────────────────────────────┼────────────────────────────────────────────┤
  │ Calibration/validation honesty │ #37 (cyt 100 vs Sveshnikova 13 nM), #38 (DTS 250 µM vs 1 mM), #39 (PLCβ 1000 vs ~5000)            │ These are Discussion content, not blockers │
  ├────────────────────────────────┼───────────────────────────────────────────────────────────────────────────────────────────────────┼────────────────────────────────────────────┤
  │ Architecture/tech              │ #32 (the UI half — data half is done), #17, #23, #41 (v0.6 microdomains)                          │ Post-dissertation                          │
  ├────────────────────────────────┼───────────────────────────────────────────────────────────────────────────────────────────────────┼────────────────────────────────────────────┤
  │ Strategic/optional             │ #49/50 webapp v2 + Vivarium, #40/36 stochastic, #12/13/35 optional biology, #43 perspective paper │ PhD-scope                                  │
  └────────────────────────────────┴───────────────────────────────────────────────────────────────────────────────────────────────────┴────────────────────────────────────────────┘

  Note #32 is half-done: the data-carving (constants→TOML, species→TSV) landed; the parameter-tweak UI is the remaining, explicitly post-dissertation part. The issue stays open for that.

  Latest output data you can report on now

  The handbook wants four results figures. Here's exactly what data exists today, mapped to that requirement:

  ┌─────────────────────────────────┬────────────────────────────────────┬─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┐
  │          Thesis figure          │            Data status             │                                                        Asset                                                        │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Architecture (schematic)        │ ✅ exists                          │ figures/v0.5/model-status-graphviz.png                                                                                   │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Validation — Dolan Fig. 4       │ ✅ exists                          │ figures/v0.5/ca-bound-free-edta-2026-06-10.png + data/phase3-summary-2026-05-06.json (cyt 104 nM, DTS 235 µM, IP₃ 50 nM, 5/5) │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Dose-response sweep             │ ✅ exists, not yet in thesis       │ dose-sweep-9x9-* (peak-ca, peak-ip3, auc-ca, rise-time lines, panels) + interactive HTML on GitHub Pages            │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ DTS overshoot (long recovery)   │ ✅ exists                          │ figures/v0.5/long-recovery-v041.png                                                                                      │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ PMCA-rate-limits / MCU findings │ ❌ claimed in draft, no figure yet │ —                                                                                                                   │
  └─────────────────────────────────┴────────────────────────────────────┴─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┘

  Two things to flag:
  1. ✅ RESOLVED 2026-06-10: draft now cites ca-bound-free-edta-2026-06-10.png (EDTA transient on the fixed endogenous-IP₃ model); v0.4.0 and 2026-05-20 are superseded.
  2. The dose-response result is your strongest novel finding and isn't in the thesis yet. The "graded upstream (IP₃ spans 50→305 nM over 5 orders of magnitude) → binary at store release (peak Ca²⁺ flat at ~436 nM) → graded
  again in the integrated response (Ca²⁺ AUC recovers 8× range)" story is exactly the kind of mechanistic insight that only falls out of an all-components-present model. That's Results Figure 3, ready to drop in.

  Low-risk, ~2-week menu

  I'll rank by reportable value per unit risk, since you're in interim-report season.

  🥇 Recommended: generate the 2 missing mechanistic-finding figures from the existing model. Your Results section already claims "PMCA Vmax rate-limits recovery" and "MCU buffering doesn't accelerate DTS refill" — but
  there's no committed data behind them. These are in-silico perturbation runs on the frozen v0.5 model (scan PMCA Vmax; knock out MCU; reuse the long-recovery + dose-sweep harness that already exists). No new biology, lowest
  possible risk, and it completes your four-figure Results section. ~2–4 days. This is the clear sweet spot.

  🥈 Thesis-support, near-zero risk: finish the Zotero bibliography (#52), write the catch-up lab book, refresh the validation-figure reference. ~1 day, makes the report submittable.

  🥉 Test scaffolding (codebase-review Priority 2): RestingDecay + CalciumTrace unit tests, @pytest.mark.slow split, add wholecell/tests/ to CI. ~4–6h, good hygiene but produces no reportable data — do it only if dev-quality
  matters more than report content right now.

  ⚠️  Achievable but I'd not start now: a new biology pathway (granules #5–8, P2Y12 #10, TP #33). Each is ~1–2 weeks of implementation — but the hard part is validation against new data, which rarely lands cleanly in a fixed
  window. Starting one mid-report risks an unvalidated half-mechanism in the repo. Better as the post-report next phase.


  The handbook wants four results figures. Here's exactly what data exists today, mapped to that requirement:

  ┌─────────────────────────────────┬────────────────────────────────────┬─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┐
  │          Thesis figure          │            Data status             │                                                        Asset                                                        │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Architecture (schematic)        │ ✅ exists                          │ figures/v0.5/model-status-graphviz.png                                                                                   │
  │          Thesis figure          │            Data status             │                                                        Asset                                                        │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Architecture (schematic)        │ ✅ exists                          │ figures/v0.5/model-status-graphviz.png                                                                                   │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Architecture (schematic)        │ ✅ exists                          │ figures/v0.5/model-status-graphviz.png                                                                                   │
  ├─────────────────────────────────┼────────────────────────────────────┼─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┤
  │ Validation — Dolan Fig. 4       │ ✅ exists                          │ figures/v0.5/ca-bound-free-edta-2026-06-10.png + data/phase3-summary-2026-05-06.json (cyt 104 nM, DTS 235 µM, IP₃ 50 nM, 5/5) │
  │ PMCA-rate-limits / MCU findings │ ❌ claimed in draft, no figure yet │ —                                                                                                                   │
  └─────────────────────────────────┴────────────────────────────────────┴─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────┘

  Two things to flag:
  1. ✅ RESOLVED 2026-06-10: draft now cites ca-bound-free-edta-2026-06-10.png (EDTA transient on the fixed endogenous-IP₃ model); v0.4.0 and 2026-05-20 are superseded.
  2. The dose-response result is your strongest novel finding and isn't in the thesis yet. The "graded upstream (IP₃ spans 50→305 nM over 5 orders of magnitude) → binary at store release (peak Ca²⁺ flat at ~436 nM) → graded
  again in the integrated response (Ca²⁺ AUC recovers 8× range)" story is exactly the kind of mechanistic insight that only falls out of an all-components-present model. That's Results Figure 3, ready to drop in.

  Low-risk, ~2-week menu

  I'll rank by reportable value per unit risk, since you're in interim-report season.

  🥇 Recommended: generate the 2 missing mechanistic-finding figures from the existing model. Your Results section already claims "PMCA Vmax rate-limits recovery" and "MCU buffering doesn't accelerate DTS refill" — but
  there's no committed data behind them. These are in-silico perturbation runs on the frozen v0.5 model (scan PMCA Vmax; knock out MCU; reuse the long-recovery + dose-sweep harness that already exists). No new biology, lowest
  possible risk, and it completes your four-figure Results section. ~2–4 days. This is the clear sweet spot.

  🥈 Thesis-support, near-zero risk: finish the Zotero bibliography (#52), write the catch-up lab book, refresh the validation-figure reference. ~1 day, makes the report submittable.

  🥉 Test scaffolding (codebase-review Priority 2): RestingDecay + CalciumTrace unit tests, @pytest.mark.slow split, add wholecell/tests/ to CI. ~4–6h, good hygiene but produces no reportable data — do it only if dev-quality
  matters more than report content right now.
  Two things to flag:
  1. ✅ RESOLVED 2026-06-10: draft now cites ca-bound-free-edta-2026-06-10.png (EDTA transient on the fixed endogenous-IP₃ model); v0.4.0 and 2026-05-20 are superseded.
  2. The dose-response result is your strongest novel finding and isn't in the thesis yet. The "graded upstream (IP₃ spans 50→305 nM over 5 orders of magnitude) → binary at store release (peak Ca²⁺ flat at ~436 nM) → graded
  again in the integrated response (Ca²⁺ AUC recovers 8× range)" story is exactly the kind of mechanistic insight that only falls out of an all-components-present model. That's Results Figure 3, ready to drop in.

  Low-risk, ~2-week menu

  I'll rank by reportable value per unit risk, since you're in interim-report season.

  🥇 Recommended: generate the 2 missing mechanistic-finding figures from the existing model. Your Results section already claims "PMCA Vmax rate-limits recovery" and "MCU buffering doesn't accelerate DTS refill" — but
  there's no committed data behind them. These are in-silico perturbation runs on the frozen v0.5 model (scan PMCA Vmax; knock out MCU; reuse the long-recovery + dose-sweep harness that already exists). No new biology, lowest
  possible risk, and it completes your four-figure Results section. ~2–4 days. This is the clear sweet spot.

  🥈 Thesis-support, near-zero risk: finish the Zotero bibliography (#52), write the catch-up lab book, refresh the validation-figure reference. ~1 day, makes the report submittable.

  🥉 Test scaffolding (codebase-review Priority 2): RestingDecay + CalciumTrace unit tests, @pytest.mark.slow split, add wholecell/tests/ to CI. ~4–6h, good hygiene but produces no reportable data — do it only if dev-quality
  matters more than report content right now.

  ⚠️  Achievable but I'd not start now: a new biology pathway (granules #5–8, P2Y12 #10, TP #33). Each is ~1–2 weeks of implementation — but the hard part is validation against new data, which rarely lands cleanly in a fixed
  window. Starting one mid-report risks an unvalidated half-mechanism in the repo. Better as the post-report next phase.

  Honesty caveats for the report itself

  Worth pre-empting in your Discussion (all already tracked as open issues, so they're defensible "known limitations" not surprises): the resting-baseline tension (#37/#38 — your 100 nM cyt / 250 µM DTS follow Dolan, but
  Sveshnikova reports 13 nM / 1 mM), the SERCA Vmax over-estimate (~2–5× literature, already in your Discussion draft), and PLCβ copy number (#39, 1000 stub vs ~5000 proteomics).

  ---
  My recommendation: 🥈 then 🥇 — lock the bibliography and figure references so the report is submittable, then spend the bulk of the two weeks generating the two perturbation figures to complete the Results section. Both
  are low-risk and directly improve the interim report.

  Want me to start by (a) generating the PMCA-Vmax / MCU-knockout perturbation runs, (b) refreshing the thesis figure references and bibliography, or (c) writing the catch-up lab book? I can also update your
  project_phase_status memory, which still says v0.4.1.